Vaccaro N
518  Ergebnisse:
Personensuche X
?
3

Pharmacodynamic differences between canagliflozin and dapag..:

Sha, S. ; Polidori, D. ; Farrell, K....
Diabetes, Obesity and Metabolism.  17 (2015)  2 - p. 188-197 , 2015
 
?
4

CCR2 antagonism in patients with type 2 diabetes mellitus: ..:

Di Prospero, N. A. ; Artis, E. ; Andrade-Gordon, P....
Diabetes, Obesity and Metabolism.  16 (2014)  11 - p. 1055-1064 , 2014
 
?
5

OP42 PHARMACODYNAMIC (PD) DIFFERENCES BETWEEN CANAGLIFLOZIN..:

Sha, S. ; Polidori, D. ; Farrell, K....
Diabetes Research and Clinical Practice.  106 (2014)  - p. S21 , 2014
 
?
6

Effects of JNJ‐38431055, a novel GPR119 receptor agonist, i..:

Katz, L. B. ; Gambale, J. J. ; Rothenberg, P. L....
Diabetes, Obesity and Metabolism.  14 (2012)  8 - p. 709-716 , 2012
 
?
7

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerabilit..:

Katz, L B ; Gambale, J J ; Rothenberg, P L...
Clinical Pharmacology & Therapeutics.  90 (2011)  5 - p. 685-692 , 2011
 
?
 
?
11

Identification of Novel Loci Shared by Juvenile Idiopathic ..:

Li, Jin ; Li, Yun R. ; Glessner, Joseph T....
Arthritis & Rheumatology.  74 (2022)  8 - p. 1420-1429 , 2022
 
?
14

The Impact of Clinical Factors, Vitamin B12 and Total Chole..:

Affaticati LM ; Buoli M ; Vaccaro N...
info:eu-repo/semantics/altIdentifier/pmid/38068810.  , 2023
 
1-15